Please assess the completion status of the following clinical trial:

Trial Title: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* hypopituitarism of at least 3 axes (TSH plus gonadotropin, somatotropin, corticotropin or ADH deficiency)~* termination of surgical or radiation treatment of pituitary tumors at least six month before study entry~* BMI of 20 - 39.9 kg/m2~* non-smoking status.~Exclusion Criteria:~* history of cardiovascular or pulmonary diseases~* current thyroxin dosage \> 1.6 µg/kg bw~* pregnancy~* epilepsy~* cerebrovascular diseases~* nodular goiter

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).